Title : CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype.

Pub. Date : 2008 Oct 21

PMID : 18854824






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP2C19 is a drug-metabolising enzyme involved in the metabolism of a number of chemotherapeutic agents including cyclophosphamide. Cyclophosphamide cytochrome P450 family 2 subfamily C member 19 Homo sapiens
2 There is increasing interest in using pharmacogenetics to "individualise medicine", however, the results of this study indicate that in a cancer population genotyping for CYP2C19 would significantly underestimate the number of phenotypic PM of drugs, such as cyclophosphamide, which may be metabolised by this enzyme. Cyclophosphamide cytochrome P450 family 2 subfamily C member 19 Homo sapiens